Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | RXRA | P19793 | 1/20 | 0.51 |
| ▸ | RXRB | P28702 | 1/20 | 0.51 |
| ▸ | UBE2N | P61088 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3913256 | 0.91 | RAB9A (0.54) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL8284596 | 0.87 | RAB9A (0.60) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL2624372 | 0.84 | GAA (0.62) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL23791532 | 0.84 | RAB9A (0.56) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL8302859 | 0.83 | RAB9A (0.59) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL801233 | 0.83 | ALDH1A1 (0.72) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL9772363 | 0.83 | RAB9A (0.52) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL11221203 | 0.82 | RAB9A (0.55) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL11225122 | 0.82 | RAB9A (0.51) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 | |
| SCHEMBL6717854 | 0.81 | RAB9A (0.58) | RAB9AKMT2AFKBP1ANPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116789700-A | Compound with visible light response, preparation method and application thereof | 北京超精核酸科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116789700-A | Compound with visible light response, preparation method and application thereof | 北京超精核酸科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20090137790-A1 | METHOD OF CAPPING OLIGONUCLEIC ACID | NIPPON SHINYAKU CO., LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2017282-A1 | METHOD OF CAPPING OLIGONUCLEIC ACID | Nippon Shinyaku Co., Ltd. (JP) | 2009-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137790-A1 | METHOD OF CAPPING OLIGONUCLEIC ACID | RNGTT, DUT, ADAR | RAB9A 4438/4885KMT2A 361/4885FKBP1A 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.